Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial
NCT00222261Phase 4Completed
- Sponsor
- Ullevål University Hospital
- Start
- Apr 2003
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary heart disease (CHD), sponsored by Ullevål University Hospital. Started Apr 2003; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00222261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222261.